Determinants of mortality from cystic fibrosis in Canada, 1970-1989

American Journal of Epidemiology

Volumn 143, Issue 10, 1996, Pages 1007-1017

  Corey, Mary ^a,c   Farewell, Vernon ^b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

cystic fibrosis; proportional hazards models; survival analysis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BURKHOLDERIA CEPACIA; CANADA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FAT INTAKE; FEMALE; HUMAN; INFANT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL;

EID: 0029924585     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008664     Document Type: Article

References (35)

1. Tizzano EF, Buchwald M. Cystic fibrosis: beyond the gene to therapy. J Pediatr 1992;120:337-49.
2. Gurwitz D, Corey M, Francis PW, et al. Perspectives in cystic fibrosis. Pediatr Clin N Am 1979;26:603-15.
3. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245: 1073-80.
4. National Institutes of Health. Statement on population screening for the cystic fibrosis gene. N Engl J Med 1990;323:70-1.
5. Warwick WJ, Pogue RE, Gerber HU, et al. Survival patterns in cystic fibrosis. J Chronic Dis 1975;28:609-22.
6. Canadian Cystic Fibrosis Foundation. Report of the Canadian Patient Data Registry 1992. Toronto: Canadian Cystic Fibrosis Foundation, 1994.
7. Statistics Canada. Canada year book 1990. Ottawa: Statistics Canada, 1990. (Statistics Canada catalogue no. 11-402E).
8. Statistics Canada. Births 1989. Health Reports, suppl no. 14, 1991.
9. Statistics Canada. Causes of death 1965-1989. Ottawa: Statistics Canada, 1967-1991.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
11. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc [B] 1972;34:187-220.
12. Corey M, Levison H, Crozier D. Five to seven year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis 1976;114:1085-92.
13. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity. Arch Dis Child 1966;41:613-35.
14. Marks MI. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr 1981;98: 173-9.
15. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104:206-10.
16. SAS Institute Inc. SAS/STAT user's guide, release 6.03 ed. Cary, NC: SAS Institute Inc, 1988.
17. SERC. EGRET-Epidemiological graphics estimation and testing package. Seattle, WA: Statistics and Epidemiology Research Corp, 1990.
18. Peron Y, Strohmenger C. Demographic and health indicators: presentation and interpretation. Ottawa: Statistics Canada, 1985. (Statistics Canada catalogue no. 82-543E).
19. White PM. Ethnic diversity in Canada. 1986 census of Canada. Ottawa: Statistics Canada, 1986. (Statistics Canada catalogue no. 98-132).
20. Gaskin K, Gurwitz D, Durie P, et al. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 1982;100:857-62.
21. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326: 1187-91.
22. Rozen R, De Braekeleer M, Daigneault J, et al. Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis. Am J Med Genet 1992;42:360-4.
23. Kristidis P, Bozon D, Corey M, et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992;50:1178-84.
24. Crozier DN. Cystic fibrosis: a not-so-fatal disease. Pediatr Clin North Am 1974;21:935-50.
25. Ramsey BW, Farrell PM, Pencharz P, and the Consensus Committee. Nutritional support and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16.
26. Pencharz PB. Energy intakes and low-fat diets in children with cystic fibrosis. (Editorial). J Pediatr Gastroenterol 1983;2: 400-2.
27. Fitzsimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993:122:1-9.
28. Kerem E, Corey M, Durie P, et al. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr 1989;114:767-73.
29. Dodge JA, Morison S, Lewis PA, et al. Cystic fibrosis in the United Kingdom, 1968-88: incidence, population and survival. Paediatr Perinatal Epidemiol 1993;7:157-66.
30. Hudson I, Phelan PD. Are age, sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis? Pediatr Pulmonol 1987;3:288-97.
31. Huang NN, Schidlow DV, Szatrowski TH, et al. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;82:871-9.
32. Corey M, McLaughlin FJ, Williams M, et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41:583-91.
33. Pedersen SS, Jensen T, Hoiby N, et al. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr Scand 1987;76:955-61.
34. Kerem E, Corey M, Gold R, et al. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990; 116:714-19.
35. Lewin LO, Byard PJ, Davis PB. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990;43:125-31.